VALN Quote, Financials, Valuation and Earnings

Cellectis SA has a net margin of -150.82% compared to Valneva SE's net margin of 1.68%. Valneva SE's return on equity of -56.21% beat Cellectis SA's return on equity of -31.08%.

Valneva SE has a consensus price target of $13.10, signalling upside risk potential of 23.47%. On the other hand Cellectis SA has an analysts' consensus of $7.25 which suggests that it could grow by 111.99%. Given that Cellectis SA has higher upside potential than Valneva SE, analysts believe Cellectis SA is more attractive than Valneva SE.

Valneva SE has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Cellectis SA has a beta of 2.855, suggesting its more volatile than the S&P 500 by 185.46%.

Valneva SE has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cellectis SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Valneva SE pays -- of its earnings as a dividend. Cellectis SA pays out -- of its earnings as a dividend.

Valneva SE quarterly revenues are $34.4M, which are smaller than Cellectis SA quarterly revenues of $35M. Valneva SE's net income of -$51.8M is lower than Cellectis SA's net income of $586.4K. Notably, Valneva SE's price-to-earnings ratio is -- while Cellectis SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Valneva SE is 4.43x versus 4.25x for Cellectis SA. Usually stocks with elevated PS ratios are considered overvalued.

DBV Technologies SA has a net margin of -150.82% compared to Valneva SE's net margin of --. Valneva SE's return on equity of -56.21% beat DBV Technologies SA's return on equity of -280.59%.

Valneva SE has a consensus price target of $13.10, signalling upside risk potential of 23.47%. On the other hand DBV Technologies SA has an analysts' consensus of $39.58 which suggests that it could grow by 92.81%. Given that DBV Technologies SA has higher upside potential than Valneva SE, analysts believe DBV Technologies SA is more attractive than Valneva SE.

Valneva SE has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DBV Technologies SA has a beta of -0.975, suggesting its less volatile than the S&P 500 by 197.455%.

Valneva SE has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DBV Technologies SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Valneva SE pays -- of its earnings as a dividend. DBV Technologies SA pays out -- of its earnings as a dividend.

Valneva SE quarterly revenues are $34.4M, which are larger than DBV Technologies SA quarterly revenues of --. Valneva SE's net income of -$51.8M is lower than DBV Technologies SA's net income of -$33M. Notably, Valneva SE's price-to-earnings ratio is -- while DBV Technologies SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Valneva SE is 4.43x versus -- for DBV Technologies SA. Usually stocks with elevated PS ratios are considered overvalued.

Nicox SA has a net margin of -150.82% compared to Valneva SE's net margin of --. Valneva SE's return on equity of -56.21% beat Nicox SA's return on equity of -43.13%.

Valneva SE has a consensus price target of $13.10, signalling upside risk potential of 23.47%. On the other hand Nicox SA has an analysts' consensus of -- which suggests that it could fall by --. Given that Valneva SE has higher upside potential than Nicox SA, analysts believe Valneva SE is more attractive than Nicox SA.

Valneva SE has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Nicox SA has a beta of -0.051, suggesting its less volatile than the S&P 500 by 105.13%.

Valneva SE has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nicox SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Valneva SE pays -- of its earnings as a dividend. Nicox SA pays out -- of its earnings as a dividend.

Valneva SE quarterly revenues are $34.4M, which are larger than Nicox SA quarterly revenues of --. Valneva SE's net income of -$51.8M is higher than Nicox SA's net income of --. Notably, Valneva SE's price-to-earnings ratio is -- while Nicox SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Valneva SE is 4.43x versus 5.89x for Nicox SA. Usually stocks with elevated PS ratios are considered overvalued.

Transgene SA has a net margin of -150.82% compared to Valneva SE's net margin of --. Valneva SE's return on equity of -56.21% beat Transgene SA's return on equity of -182.92%.

Valneva SE has a consensus price target of $13.10, signalling upside risk potential of 23.47%. On the other hand Transgene SA has an analysts' consensus of -- which suggests that it could fall by --. Given that Valneva SE has higher upside potential than Transgene SA, analysts believe Valneva SE is more attractive than Transgene SA.

Valneva SE has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Transgene SA has a beta of 43.826, suggesting its more volatile than the S&P 500 by 4282.564%.

Valneva SE has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Transgene SA offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Valneva SE pays -- of its earnings as a dividend. Transgene SA pays out -- of its earnings as a dividend.

Valneva SE quarterly revenues are $34.4M, which are larger than Transgene SA quarterly revenues of $105.2K. Valneva SE's net income of -$51.8M is higher than Transgene SA's net income of --. Notably, Valneva SE's price-to-earnings ratio is -- while Transgene SA's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Valneva SE is 4.43x versus 1,122.44x for Transgene SA. Usually stocks with elevated PS ratios are considered overvalued.